Periodic Reporting for period 1 - IL7RsignaTHER (Antibody-based IL-7R targeted therapies)

Acute lymphoblastic leukemia (ALL), a highly aggressive hematological cancer, is the most frequent childhood malignancy and the second most common acute leukemia in adults. Despite remarkable improvements in treatment outcome of pediatric cases using conventional chemotherapy...